These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15281533)

  • 21. Propofol Infusion Syndrome: An Early and Unusual Electrocardiographic Pattern.
    Dell'Angela L; Gatti G; Morosin M; Lardieri G
    J Cardiothorac Vasc Anesth; 2020 Jul; 34(7):2004-2006. PubMed ID: 31732379
    [No Abstract]   [Full Text] [Related]  

  • 22. Non-acidotic propofol infusion syndrome.
    Blum JM; Brunsvold ME
    Br J Anaesth; 2009 Oct; 103(4):617-8. PubMed ID: 19749121
    [No Abstract]   [Full Text] [Related]  

  • 23. Dark green discoloration of the urine after prolonged propofol infusion: a case report.
    Ku BD; Park KC; Yoon SS
    J Clin Pharm Ther; 2011 Dec; 36(6):734-6. PubMed ID: 21083675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score.
    Schmidt M; Burrell A; Roberts L; Bailey M; Sheldrake J; Rycus PT; Hodgson C; Scheinkestel C; Cooper DJ; Thiagarajan RR; Brodie D; Pellegrino V; Pilcher D
    Eur Heart J; 2015 Sep; 36(33):2246-56. PubMed ID: 26033984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenging Dogma in Arteriovenous Malformation Surgery: Personal Reflections and Lessons Learned from 350 Cases.
    Cohen-Gadol A
    World Neurosurg; 2020 Jul; 139():83-89. PubMed ID: 31954901
    [No Abstract]   [Full Text] [Related]  

  • 26. Extra corporeal membrane oxygenation in the therapy of cardiogenic shock (ECMO-CS): rationale and design of the multicenter randomized trial.
    Ostadal P; Rokyta R; Kruger A; Vondrakova D; Janotka M; Smíd O; Smalcova J; Hromadka M; Linhart A; Bělohlávek J
    Eur J Heart Fail; 2017 May; 19 Suppl 2():124-127. PubMed ID: 28470919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival of propofol infusion syndrome in a head-injured patient.
    Corbett SM; Moore J; Rebuck JA; Rogers FB; Greene CM
    Crit Care Med; 2006 Sep; 34(9):2479-83. PubMed ID: 16791112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adult extracorporeal life support: a failed or forgotten concept?
    Colafranceschi AS; Monteiro AJ; Canale LS; Campos LA; Montera MW; Silva PR; Fernandes MR; Pinto Ade A; Molas SM; Mesquita ET
    Arq Bras Cardiol; 2008 Jul; 91(1):34-41. PubMed ID: 18660943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracorporeal membrane oxygenation in treatment of cardiogenic shock caused by acute myocarditis.
    Wu IH; Ko WJ; Chou NK; Chao A; Lin FY
    J Formos Med Assoc; 1998 May; 97(5):364-6. PubMed ID: 9610063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Propofol infusion syndrome].
    Trampitsch E; Oher M; Pointner I; Likar R; Jost R; Schalk HV
    Anaesthesist; 2006 Nov; 55(11):1166-8. PubMed ID: 17021888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tier approach to propofol infusion syndrome.
    Bader MK; Vislosky M
    Crit Care Nurse; 2008 Oct; 28(5):22-3; author reply 23. PubMed ID: 18827082
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of Extracorporeal Membrane Oxygenation in Refractory Cardiogenic Shock.
    Tariq S; Gass A
    Cardiol Rev; 2016; 24(1):26-9. PubMed ID: 26440651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Propofol infusion syndrome in a patient with sepsis.
    De Waele JJ; Hoste E
    Anaesth Intensive Care; 2006 Oct; 34(5):676-7. PubMed ID: 17061649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advanced Percutaneous Mechanical Circulatory Support Devices for Cardiogenic Shock.
    Miller PE; Solomon MA; McAreavey D
    Crit Care Med; 2017 Nov; 45(11):1922-1929. PubMed ID: 28857849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Feasibility study of controlled hypotension induced with combination of propofol and desflurane in craniotomy].
    Wang JL; Lin H; Jin JG; Zhong M; Zhuge QC
    Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(3):212-5. PubMed ID: 12812664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous extracorporeal membrane oxygenation for cardiogenic shock due to acute fulminant myocarditis.
    Fayssoil A; Nardi O; Orlikowski D; Combes A; Chastre J; Annane D
    Ann Thorac Surg; 2010 Feb; 89(2):614-6. PubMed ID: 20103358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracorporeal Membrane Oxygenation Support for Incessant Tachyarrhythmia-Induced Severe Cardiogenic Shock.
    Zhang ZP; Su X; Wang JY; Liu CW
    Chin Med J (Engl); 2018 Sep; 131(17):2139-2140. PubMed ID: 30127234
    [No Abstract]   [Full Text] [Related]  

  • 38. Propofol infusion syndrome in anaesthesia and intensive care medicine.
    Fudickar A; Bein B; Tonner PH
    Curr Opin Anaesthesiol; 2006 Aug; 19(4):404-10. PubMed ID: 16829722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two-stage weaning strategy using veno-veno-arterial perfusion for patients on extracorporeal membrane oxygenation following cardiogenic shock.
    Haldenwang PL; Baumann A; Elghannam M; Schlömicher M; Buchwald D; Klak K; Strauch JT
    Perfusion; 2019 Nov; 34(8):689-695. PubMed ID: 31081459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracorporeal life support for phaeochromocytoma-induced cardiogenic shock: a systematic review.
    Matteucci M; Kowalewski M; Fina D; Jiritano F; Meani P; Raffa GM; Aldobayyan I; Beghi C; Maessen J; Lorusso R
    Perfusion; 2020 May; 35(1_suppl):20-28. PubMed ID: 32397890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.